Several bacteria from the Clostridium genus produce botulinum neurotoxins—the most potent biological toxins known—that cause botulism by blocking neurotransmitter release from nerves. Typically, the ...

In a comprehensive research study, scientists have uncovered a previously unknown mechanism explaining how neurons survive botulinum neurotoxin type A (BoNT/A) exposure, despite the toxin's powerful ...

CHICAGO, IL—The use of botulinum toxin type A in patients undergoing cardiac surgery does not seem to reduce the rate of postoperative atrial fibrillation (AF) overall, according to the phase II NOVA ...

The proper management of pain is a critical issue in the practice of medicine. Despite the availability of a large number of analgesic medications, management of pain that is refractory to ...

Botulinum toxin A (BTX-A) is produced by the Gram-positive, anaerobic bacillus Clostridium botulinum, and is regarded as the most potent neurotoxin known to man The effects of BTX-A include inhibition ...

Please provide your email address to receive an email when new articles are posted on . Injections yielded significant improvements in visual analog scale pain and Quick-DASH score, as well as skin ...

Two research groups have designed chimeric fusion proteins that constitute a new “trojan horse” approach to neutralize lethal botulinum toxins. Botulinum neurotoxins (BoNTs)—a family of bacterial ...

Botulinum toxin (BTX) has been used at Baylor’s Parkinson’s Disease Center and Movement Disorders Clinic (PDCMDC) in the treatment of dystonia and related disorders since 1983. Its safety and efficacy ...

Please provide your email address to receive an email when new articles are posted on . Some botulinum toxin type A injection formulations have a faster onset, whereas others were shown to last longer ...

The CDC reported that three individuals were hospitalized with botulism-type symptoms in May and June following self-injection of botulinum toxin they purchased online for cosmetic use. The case ...